Search Funding Opportunities

Search by category

PKD Foundation: Polycystic Kidney Disease Research Grants

Grant Amount: $160,000 over two years
Deadline: Pre-application due August 15, 2022
Category: Kidney Research,
Additional Information

The PKD Foundation’s principal mission is to support basic, translational, and clinical research to benefit patients with autosomal dominant and autosomal recessive polycystic kidney disease (ADPKD and ARPKD).

To that end, the foundation invites applications to its research program. Through the program, grants of up to $80,000 per year for up to two years will be awarded to support basic research that enhances understanding of the molecular basis of PKD and its pathobiology; translational research that accelerates the development of predictive and therapeutic strategies for PKD; clinical research, such as small pilot studies; and epidemiology/data analysis research to conduct secondary data analyses utilizing existing database resources, or to develop new statistical methodologies or test hypotheses using existing data.

Special consideration will be given to proposed research in the following areas: autosomal recessive PKD (ARPKD); ADPKD in children; biomarker discovery and validation; innovative approaches to machine learning; lifestyle interventions (e.g., in dietary habits); epidemiology/ data analysis (e.g., using existing datasets); extra-renal manifestations of PKD, including but not limited to congenital hepatic fibrosis, polycystic liver disease, and intracranial aneurysms; and clinical care disparities (e.g., race, ethnicity, socioeconomic status, rural vs. urban).

To be eligible, applicants must have an MD, PhD, or equivalent degree and hold a faculty appointment at the institution where the research will be conducted. Applicants need not be citizens of the U.S.

Pre-applications are due August 15, 2022, and selected applicants will be invited to submit a full application due in January 2023.

Please contact Lynn Wong if you are interested in applying to this opportunity.

Learn More